Archives of cardiovascular diseases · 2026
Rheumatic lesions of the pulmonary valve: A systematic review of the literature.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nacanabo Martin Wendlassida, Tall-Thiam Anna, Seghda André Arthur Taryètba, Lengani Ella Hatoula, Thiombiano Prisca Lamoudi, Dah Claudine Djième, Loya-Abouga Mureille, Yaméogo Aimé Arsène, Ouattara-Zingé Adolphe Benjamin, Millogo Georges Christian Rosario, Kologo Jonas Koudougou, Kambiré Yibar, Yaméogo Valentin Nobila, Samadoulougou André Koudnoaga, Zabsonré Patrice
Аннотация
BACKGROUND: Rheumatic pulmonary valve disease accounts for<1% of cases of rheumatic heart disease. Because of its rarity, this valvular disease is often overlooked and underdiagnosed.
AIM: To conduct a systematic review of reported cases of rheumatic pulmonary valve disease worldwide.
METHODS: Studies reporting confirmed cases of rheumatic pulmonary valve disease, and providing sufficient clinical, diagnostic, therapeutic or follow-up data were included. Duplicate checking, selection, data extraction and quality assessment of the included studies were carried out by two reviewers, independently. The Joanna Briggs Institute critical appraisal tools were used for quality assessment. The process did not result in a meta-analysis because of significant heterogeneity and a lack of data. The review protocol is registered on the Prospective Registry of Systematic Reviews (CRD420261341732).
RESULTS: We identified 909 publications across the six databases. Following deduplication and selection, we included a total of 30 studies involving 35 patients, published between 1931 and 2025. Case reports predominated, accounting for 87% of studies (n=26); case series accounted for 13% (n=4). Age ranged from 3 to 83 years (median 29 years). There was a female predominance (n=20; 57%). India accounted for 37% of cases (n=13), followed by the USA with 11% (n=4). Only 46% of patients (n=16) presented with acute rheumatic fever or pre-existing rheumatic heart disease on admission. Dyspnoea was a constant symptom in all patients. Seven patients (20%) presented with atrial fibrillation. A procedure was performed in 74% of cases (n=26): pulmonary valve replacement in 40% (n=14); balloon dilation in 11% (n=4); and intraoperative commissurotomy in 20% (n=7). The clinical outcome was favourable in 74% of the documented cases (n=26).
CONCLUSIONS: Rheumatic pulmonary valve disease is a rare condition, but is likely to be underdiagnosed and underreported; it most commonly forms part of a quadrivalent valve disease. This review highlights the need for increased clinical and paraclinical vigilance when assessing the pulmonary valve in rheumatic heart disease.
AIM: To conduct a systematic review of reported cases of rheumatic pulmonary valve disease worldwide.
METHODS: Studies reporting confirmed cases of rheumatic pulmonary valve disease, and providing sufficient clinical, diagnostic, therapeutic or follow-up data were included. Duplicate checking, selection, data extraction and quality assessment of the included studies were carried out by two reviewers, independently. The Joanna Briggs Institute critical appraisal tools were used for quality assessment. The process did not result in a meta-analysis because of significant heterogeneity and a lack of data. The review protocol is registered on the Prospective Registry of Systematic Reviews (CRD420261341732).
RESULTS: We identified 909 publications across the six databases. Following deduplication and selection, we included a total of 30 studies involving 35 patients, published between 1931 and 2025. Case reports predominated, accounting for 87% of studies (n=26); case series accounted for 13% (n=4). Age ranged from 3 to 83 years (median 29 years). There was a female predominance (n=20; 57%). India accounted for 37% of cases (n=13), followed by the USA with 11% (n=4). Only 46% of patients (n=16) presented with acute rheumatic fever or pre-existing rheumatic heart disease on admission. Dyspnoea was a constant symptom in all patients. Seven patients (20%) presented with atrial fibrillation. A procedure was performed in 74% of cases (n=26): pulmonary valve replacement in 40% (n=14); balloon dilation in 11% (n=4); and intraoperative commissurotomy in 20% (n=7). The clinical outcome was favourable in 74% of the documented cases (n=26).
CONCLUSIONS: Rheumatic pulmonary valve disease is a rare condition, but is likely to be underdiagnosed and underreported; it most commonly forms part of a quadrivalent valve disease. This review highlights the need for increased clinical and paraclinical vigilance when assessing the pulmonary valve in rheumatic heart disease.